Free Trial

Tilray (TLRY) Competitors

Tilray logo
$0.68 0.00 (-0.48%)
As of 12:28 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

TLRY vs. CRON, CDXC, USNA, MNMD, SNDL, ACB, BTMD, MDWD, CGC, and FTLF

Should you be buying Tilray stock or one of its competitors? The main competitors of Tilray include Cronos Group (CRON), ChromaDex (CDXC), USANA Health Sciences (USNA), Mind Medicine (MindMed) (MNMD), SNDL (SNDL), Aurora Cannabis (ACB), biote (BTMD), MediWound (MDWD), Canopy Growth (CGC), and FitLife Brands (FTLF). These companies are all part of the "medicinals & botanicals" industry.

Tilray vs.

Cronos Group (NASDAQ:CRON) and Tilray (NASDAQ:TLRY) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their community ranking, analyst recommendations, dividends, media sentiment, profitability, valuation, earnings, institutional ownership and risk.

Cronos Group received 16 more outperform votes than Tilray when rated by MarketBeat users. Likewise, 61.13% of users gave Cronos Group an outperform vote while only 59.26% of users gave Tilray an outperform vote.

CompanyUnderperformOutperform
Cronos GroupOutperform Votes
464
61.13%
Underperform Votes
295
38.87%
TilrayOutperform Votes
448
59.26%
Underperform Votes
308
40.74%

Cronos Group has a beta of 0.89, suggesting that its stock price is 11% less volatile than the S&P 500. Comparatively, Tilray has a beta of 2.13, suggesting that its stock price is 113% more volatile than the S&P 500.

8.7% of Cronos Group shares are owned by institutional investors. Comparatively, 9.4% of Tilray shares are owned by institutional investors. 6.9% of Cronos Group shares are owned by insiders. Comparatively, 0.9% of Tilray shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Tilray has a net margin of -30.95% compared to Cronos Group's net margin of -42.65%. Cronos Group's return on equity of -2.56% beat Tilray's return on equity.

Company Net Margins Return on Equity Return on Assets
Cronos Group-42.65% -2.56% -2.47%
Tilray -30.95%-4.40%-3.57%

Cronos Group has higher earnings, but lower revenue than Tilray. Tilray is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cronos Group$117.62M6.07-$73.96M$0.1018.65
Tilray$210.48M3.03-$244.98M-$0.30-2.27

Cronos Group currently has a consensus target price of $3.00, suggesting a potential upside of 60.86%. Tilray has a consensus target price of $2.70, suggesting a potential upside of 296.48%. Given Tilray's stronger consensus rating and higher possible upside, analysts clearly believe Tilray is more favorable than Cronos Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cronos Group
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Tilray
0 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.40

In the previous week, Tilray had 10 more articles in the media than Cronos Group. MarketBeat recorded 16 mentions for Tilray and 6 mentions for Cronos Group. Tilray's average media sentiment score of 0.49 beat Cronos Group's score of 0.12 indicating that Tilray is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cronos Group
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Tilray
7 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Tilray beats Cronos Group on 10 of the 18 factors compared between the two stocks.

Remove Ads
Get Tilray News Delivered to You Automatically

Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TLRY vs. The Competition

MetricTilrayMedicinals & botanicals IndustryStaples SectorNASDAQ Exchange
Market Cap$638.54M$1.18B$16.75B$8.32B
Dividend YieldN/AN/A2.86%4.02%
P/E Ratio-2.2710.6016.2119.35
Price / Sales3.036.112.6796.59
Price / CashN/A10.4016.3934.64
Price / Book0.161.226.744.48
Net Income-$244.98M-$54.73M$731.75M$247.04M
7 Day Performance0.78%-3.29%0.04%3.44%
1 Month Performance-15.61%-15.45%2.93%-2.48%
1 Year Performance-68.33%-39.44%3.80%4.92%

Tilray Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TLRY
Tilray
1.8103 of 5 stars
$0.68
-0.5%
$2.70
+297.6%
-70.5%$638.54M$210.48M-2.272,650
CRON
Cronos Group
1.4646 of 5 stars
$1.91
+0.8%
$3.00
+57.5%
-28.0%$728.72M$117.62M-14.65450News Coverage
CDXC
ChromaDex
4.3124 of 5 stars
$7.96
+1.5%
$9.03
+13.6%
N/A$618.50M$99.60M796.30120
USNA
USANA Health Sciences
4.4141 of 5 stars
$28.39
-2.6%
$36.00
+26.8%
-43.1%$536.71M$854.50M10.031,900
MNMD
Mind Medicine (MindMed)
1.2951 of 5 stars
$6.46
+1.7%
$25.11
+288.7%
-29.2%$486.05MN/A-2.8540
SNDL
SNDL
2.8741 of 5 stars
$1.57
+3.6%
$3.25
+107.7%
-9.1%$411.24M$911.22M-5.052,516Earnings Report
ACB
Aurora Cannabis
0.8273 of 5 stars
$4.46
+1.0%
N/A-6.0%$244.39M$320.81M89.121,073
BTMD
biote
3.5729 of 5 stars
$4.00
+6.3%
$8.00
+100.3%
-38.1%$217.08M$197.19M15.37194Positive News
High Trading Volume
MDWD
MediWound
1.4038 of 5 stars
$18.91
+2.0%
$31.33
+65.7%
+3.0%$203.96M$19.72M-6.5280Earnings Report
Analyst Revision
CGC
Canopy Growth
2.7134 of 5 stars
$1.18
+6.8%
$2.00
+70.2%
-84.9%$186.37M$276.75M-0.313,150
FTLF
FitLife Brands
4.4285 of 5 stars
$13.89
-0.4%
$20.50
+47.6%
+19.7%$127.93M$62.76M16.4420
Remove Ads

Related Companies and Tools


This page (NASDAQ:TLRY) was last updated on 3/25/2025 by MarketBeat.com Staff
From Our Partners